Advanced search
Publication Cover
Leukemia & Lymphoma Volume 43, 2002 - Issue 4
Submit an article Journal homepage
41
Views
19
CrossRef citations to date
0
Altmetric
Research Article

Graft versus Burkitt's Lymphoma Effect after Allogeneic Marrow Transplantation

A.P. Grigg Department of Clinical Haematology and Medical Oncology, The Royal Melbourne Hospital, Grattan Street, Parkville, Victoria 3050, Australia
&
J.F. Seymour Department of Haematology, Peter MacCallum Cancer Institute, Melbourne, Australia
Pages 889-891 | Published online: 01 Jul 2009

  • Harris, N.L., Jaffe, E.S., Stein, H., et al., (1994) "Revised European American classification of lymphoid neoplasms: a proposal from the international lymphoma study group", Blood 84, 1361-1392.
  • Mead, O. and Sydes, M. (1999). "International evaluation of National Cancer Institute protocol 89-C-41 (with minor modifications) in adults with non-HTV related Burkitt's lymphoma- a United Kingdom Lymphoma Group (UKLG) study", Proc. ASCO 18:12a, (abstr. 39).
  • Sweetenham, J.W. Pearce, R., Taghipour, G., Biaise, D., Gisselbrecht, C. and Goldstone, A.M. (1996) "Adult Burkitt's and Burkitl-like non-Hodgkin's lymphoma-outcome for patients treated with high-dose therapy and autologous stein-cell transplantation in first remission or at relapse: results from the European Group for Blood and Marrow Transplantation". J. Clin. Oncol. 14, 2465-2472.
  • Weinthal, J.A., Goldman, S.C. and Lenarsky, C. (2000) "Successful treatment of relapsed Burkitt's lymphoma using unrelated cord blood transplantation as consolidation therapy". Bone Marrow Transplant 25, 1311-1313.
  • Van Besien, K. W., Mehra, R.C., Girall, S.A., Kantarjian, H.M., Pugh, W.C., Khouri, I.E. Moon, Y., Williams, P., Andersson, B.S., Przepiorka, D., McCarthy, P.I., Gajewski, J.L., Deisseroth, A.B., Cabanillas, F.F. and Champlin, R. (1996) "Allogeneic bone marrow transplantation for poor-prognosis lymphoma: response, toxicity and survival depend on disease histology". Am. J Med 100, 299-307.
  • Petersen, F.B., Applebaum, F.R., Bigelow, C.L., et al., (1989) "High-dose cytosine arabinoside. total body irradiation and marrow transplantation for advanced malignant lympboma", Bone Marrow Transplant 4, 483-488.
  • Ungkanont, A., Mongkonsritrakoon, W. and Jootar, S.S. (2000) "Allogeneic stem cell transplantation in a patient with refractory Burkitt's lymphoma using non-myelonblative conditioning regimen", Bone Marrow Transplant 26, 1351-1354.
  • Van Besien, K.W., de Lima, M., Giralt, S.A., Moore, D.H., Khouri, I.F., Rondon, G., Mehra, R., Andersson, B.S., Dyer, C. Cleary, K., Przepiorka, D., Gajewski, J.L. and Champlin, R.E. (1997) "Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphorna effect", Bone Marrow Transplant 19, 982-997.
  • Collins, R.H., Goldstein, S., Giralt, S., Levine, J., Porter, D., Drobyski, W., Barren, J., Johnson, M., Kirk, A., Horowitz, M. and Parker, P. (2000) "Donor leukocyte infusions in acute lymphocytic leukemia". Bone Marrow Transplant 26, 511-516.
  • Chong, G., Byrnes, G., Szer, J. and Grigg, A. (2000) "Extramedullary relapse after allogeneic bone marrow transplantation for haematological malignancy". Bone Marrow Transplant 26, 1011-1015.
  • Thangavelu, M., Olopade, O., Beckham, E., et al., (1990) "Clinical, morphologic, and cytogenctic characteristics of patients with lymphoid malignancies characterized by both t(14;18)(q32;q21) and t(8.14)(q24:q32) or t(8:22)(q24;q11)", Genes Chromosomes Cancer 3, 147-158.
  • Thomas, D.A., Cortes, J., O'Brien, S., et al., (1999) "Hyper-CVAD program in Burkitt's-type adult acute Jymphoblastic leukemia", J. Clin. Oncol 17, 2461-2470.
  • Yang, H., Rosove, M.H. and Figlin, R.A. (1999) 'Tumour lysis syndrome occurring after the administration of rituximab in lymphoproliferative disorders: high-grade non-Hodgkin's lymphoma and chronic lymphocytic leukemia". Am. J. Hematol. 62, 247-250.
  • Demidem, A., Lam, T., Alas, S., et al. (1997) "Chimeric anti-CD20 (IDEC-C2B8) monoclonal antibody sensitizes a B cell lymphoma cell line to cell killing by cytotoxic drugs", Cancer Biother. Radiopharm. 12, 177-186.
  • Raizer, J.J., Lisa, D.M., Zelenetz, A.D. and Lauren, A.E. (2000). "Activity of rituximab in primary central nervous system lymphoma PCNSL". Proc. ASCO 19: 166a (Abstr. 642).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.